ARCHIVES

In Brief: Carbone To Leave NCI for Wisconsin ACS’ Holleb Says Tobacco Industry Tries to Hide Ad Warning

This article is from The Cancer Letter archive.

Vol. 01 No. 40 | October 3, 1975

Download PDF Visit The Full Archive

Related Articles

FA Drug Approval on Activity, Rather Than Survival Urged By NCU

January 13, 1989

ODAC Okays Photofrin for Obstructive Esophageal Cancer

September 23, 1994

Breast Cancer Working Group Lists Research Needed

July 1, 1988

FDA Caps Advisors’ Holdings To $50,000 In Firms Affected By Committee Meetings.

August 8, 2008

Troubles of Two Landmark Cancer Drugs, Celebrex and Iressa, Likely to Shape cancer Prevention, FDA Policy. FDA Mulls Withdrawal of Iressa.

January 7, 2005

DCT Board Okays Recompetitions

June 21, 1985